CHRNA7 Gene and Response to Cholinesterase Inhibitors in an Italian Cohort of Alzheimer's Disease Patients

Ferdinando Clarelli, Elisabetta Mascia, Roberto Santangelo, Salvatore Mazzeo, Giacomo Giacalone, Daniela Galimberti, Federica Fusco, Marta Zuffi, Chiara Fenoglio, Massimo Franceschi, Elio Scarpini, Gianluigi Forloni, Giuseppe Magnani, Giancarlo Comi, Diego Albani, Filippo Martinelli Boneschi

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Previous studies suggest that genetic variants in CHRNA7, which encodes for the major subunit of the acetylcholine receptor (α7-nAChR), are associated with the clinical response to cholinesterase inhibitors (ChEI) in Alzheimer's disease (AD) patients. We sought to replicate the association of two SNPs in the CHRNA7 gene, rs6494223 and rs8024987, with response to ChEI treatment in an Italian cohort of 169 AD patients, further extending the study to gene-level analysis. None of the tested variants was associated with clinical response. However, rs6494223 showed a consistent effect direction (OR=1.4; p=0.17), which after meta-analysis with previous study yielded a significant result (OR=1.57, p=0.02, I2=0).

Original languageEnglish
Pages (from-to)1203-1208
Number of pages6
JournalJournal of Alzheimer's Disease
Volume52
Issue number4
DOIs
Publication statusPublished - 2016

Fingerprint

Cholinesterase Inhibitors
Alzheimer Disease
Cholinergic Receptors
Genes
Single Nucleotide Polymorphism
Meta-Analysis
Therapeutics
Direction compound

Keywords

  • Alpha7 nicotinic acetylcholine receptor
  • Alzheimer's disease
  • biomarkers
  • cholinesterase inhibitors
  • pharmacogenetics

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Geriatrics and Gerontology
  • Clinical Psychology

Cite this

Clarelli, F., Mascia, E., Santangelo, R., Mazzeo, S., Giacalone, G., Galimberti, D., ... Martinelli Boneschi, F. (2016). CHRNA7 Gene and Response to Cholinesterase Inhibitors in an Italian Cohort of Alzheimer's Disease Patients. Journal of Alzheimer's Disease, 52(4), 1203-1208. https://doi.org/10.3233/JAD-160074

CHRNA7 Gene and Response to Cholinesterase Inhibitors in an Italian Cohort of Alzheimer's Disease Patients. / Clarelli, Ferdinando; Mascia, Elisabetta; Santangelo, Roberto; Mazzeo, Salvatore; Giacalone, Giacomo; Galimberti, Daniela; Fusco, Federica; Zuffi, Marta; Fenoglio, Chiara; Franceschi, Massimo; Scarpini, Elio; Forloni, Gianluigi; Magnani, Giuseppe; Comi, Giancarlo; Albani, Diego; Martinelli Boneschi, Filippo.

In: Journal of Alzheimer's Disease, Vol. 52, No. 4, 2016, p. 1203-1208.

Research output: Contribution to journalArticle

Clarelli, Ferdinando ; Mascia, Elisabetta ; Santangelo, Roberto ; Mazzeo, Salvatore ; Giacalone, Giacomo ; Galimberti, Daniela ; Fusco, Federica ; Zuffi, Marta ; Fenoglio, Chiara ; Franceschi, Massimo ; Scarpini, Elio ; Forloni, Gianluigi ; Magnani, Giuseppe ; Comi, Giancarlo ; Albani, Diego ; Martinelli Boneschi, Filippo. / CHRNA7 Gene and Response to Cholinesterase Inhibitors in an Italian Cohort of Alzheimer's Disease Patients. In: Journal of Alzheimer's Disease. 2016 ; Vol. 52, No. 4. pp. 1203-1208.
@article{f1f1f33afa3f40a1b583ea8379a2c6c3,
title = "CHRNA7 Gene and Response to Cholinesterase Inhibitors in an Italian Cohort of Alzheimer's Disease Patients",
abstract = "Previous studies suggest that genetic variants in CHRNA7, which encodes for the major subunit of the acetylcholine receptor (α7-nAChR), are associated with the clinical response to cholinesterase inhibitors (ChEI) in Alzheimer's disease (AD) patients. We sought to replicate the association of two SNPs in the CHRNA7 gene, rs6494223 and rs8024987, with response to ChEI treatment in an Italian cohort of 169 AD patients, further extending the study to gene-level analysis. None of the tested variants was associated with clinical response. However, rs6494223 showed a consistent effect direction (OR=1.4; p=0.17), which after meta-analysis with previous study yielded a significant result (OR=1.57, p=0.02, I2=0).",
keywords = "Alpha7 nicotinic acetylcholine receptor, Alzheimer's disease, biomarkers, cholinesterase inhibitors, pharmacogenetics",
author = "Ferdinando Clarelli and Elisabetta Mascia and Roberto Santangelo and Salvatore Mazzeo and Giacomo Giacalone and Daniela Galimberti and Federica Fusco and Marta Zuffi and Chiara Fenoglio and Massimo Franceschi and Elio Scarpini and Gianluigi Forloni and Giuseppe Magnani and Giancarlo Comi and Diego Albani and {Martinelli Boneschi}, Filippo",
year = "2016",
doi = "10.3233/JAD-160074",
language = "English",
volume = "52",
pages = "1203--1208",
journal = "Journal of Alzheimer's Disease",
issn = "1387-2877",
publisher = "IOS Press",
number = "4",

}

TY - JOUR

T1 - CHRNA7 Gene and Response to Cholinesterase Inhibitors in an Italian Cohort of Alzheimer's Disease Patients

AU - Clarelli, Ferdinando

AU - Mascia, Elisabetta

AU - Santangelo, Roberto

AU - Mazzeo, Salvatore

AU - Giacalone, Giacomo

AU - Galimberti, Daniela

AU - Fusco, Federica

AU - Zuffi, Marta

AU - Fenoglio, Chiara

AU - Franceschi, Massimo

AU - Scarpini, Elio

AU - Forloni, Gianluigi

AU - Magnani, Giuseppe

AU - Comi, Giancarlo

AU - Albani, Diego

AU - Martinelli Boneschi, Filippo

PY - 2016

Y1 - 2016

N2 - Previous studies suggest that genetic variants in CHRNA7, which encodes for the major subunit of the acetylcholine receptor (α7-nAChR), are associated with the clinical response to cholinesterase inhibitors (ChEI) in Alzheimer's disease (AD) patients. We sought to replicate the association of two SNPs in the CHRNA7 gene, rs6494223 and rs8024987, with response to ChEI treatment in an Italian cohort of 169 AD patients, further extending the study to gene-level analysis. None of the tested variants was associated with clinical response. However, rs6494223 showed a consistent effect direction (OR=1.4; p=0.17), which after meta-analysis with previous study yielded a significant result (OR=1.57, p=0.02, I2=0).

AB - Previous studies suggest that genetic variants in CHRNA7, which encodes for the major subunit of the acetylcholine receptor (α7-nAChR), are associated with the clinical response to cholinesterase inhibitors (ChEI) in Alzheimer's disease (AD) patients. We sought to replicate the association of two SNPs in the CHRNA7 gene, rs6494223 and rs8024987, with response to ChEI treatment in an Italian cohort of 169 AD patients, further extending the study to gene-level analysis. None of the tested variants was associated with clinical response. However, rs6494223 showed a consistent effect direction (OR=1.4; p=0.17), which after meta-analysis with previous study yielded a significant result (OR=1.57, p=0.02, I2=0).

KW - Alpha7 nicotinic acetylcholine receptor

KW - Alzheimer's disease

KW - biomarkers

KW - cholinesterase inhibitors

KW - pharmacogenetics

UR - http://www.scopus.com/inward/record.url?scp=84974605078&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84974605078&partnerID=8YFLogxK

U2 - 10.3233/JAD-160074

DO - 10.3233/JAD-160074

M3 - Article

VL - 52

SP - 1203

EP - 1208

JO - Journal of Alzheimer's Disease

JF - Journal of Alzheimer's Disease

SN - 1387-2877

IS - 4

ER -